Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

Conditions:   Gastric Adenocarcinoma;   Esophageal Adenocarcinoma;   Metastasis;   HER-2 Gene Amplification
Interventions:   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: 5 fluorouracil;   Drug: Trastuzumab;   Drug: Avelumab
Sponsors:   Michael Sangmin Lee;   EMD Serono;   University of North Carolina, Chapel Hill
Not yet recruiting

http://bit.ly/2EFbBl3